New drug trial aims to control arthritis in kids

NCT ID NCT06751238

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study is testing a drug called secukinumab, given as an IV infusion, in 20 children aged 2 to 17 with juvenile psoriatic arthritis. The main goals are to see how the drug moves through the body and to check its safety over up to 6 years. This is an early-stage trial, so it focuses on dosing and side effects rather than whether the drug works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: secukinumab (a biologic drug given by IV infusion)
What this could lead to: If successful, this could provide a treatment option for children with juvenile psoriatic arthritis that helps control the disease over the long term.
What could go wrong: This is a very early phase 1 study with only 20 participants, so it is primarily checking safety and drug levels, not effectiveness. The drug may cause side effects and may not work for all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUVENILE PSORIATIC ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

juvenile idiopathic arthritis psoriasis-related juvenile idiopathic arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

JUVENILE PSORIATIC ARTHRITIS

Contacts and locations

Locations

Ann and Robert H Lurie Childs Hosp
RECRUITING

Chicago, Illinois, 60611, United States
Childrens Hosp Pittsburgh UPMC
RECRUITING

Pittsburgh, Pennsylvania, 15224, United States
Cincinnati Childrens Hospital
RECRUITING

Cincinnati, Ohio, 45229, United States
Legacy Emanuel Research Hosp Portland
RECRUITING

Portland, Oregon, 97232, United States
Levine Childrens Hospital
RECRUITING

Charlotte, North Carolina, 28203, United States
Texas Arthritis Center
RECRUITING

El Paso, Texas, 79902, United States
Univ Hosp Cleveland Medical Center
RECRUITING

Cleveland, Ohio, 44106-5028, United States
University of Florida
RECRUITING

Gainesville, Florida, 32610 8068, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.